Navigation Links
POLYSORB™ Soft Tissue Reattachment System, 2mm

ProductsPOLYSORB™ Soft Tissue Reattachment System, 2mm
Company USS Sports Medicine
Item POLYSORB™ Soft Tissue Reattachment System, 2mm
Features 
  • Anchor manufactured from proprietary blend of PLA/PGA
  • Prepackaged in disposable inserter with insertion indicators
  • Indicators on device provide a visual sign to the surgeon when the anchor is fully seated
  • Drill Guide with serrations on the distal tip and a slot running the length of the tube
  • Provides excellent stability
  • The slot allows the surgeon to pass suture out of the guide if necessary
    • Description The USS Sports Medicine™ POLYSORB™ Soft Tissue Anchor 2 mm is a resorbable repair device used to attach soft tissue to bone using sutures. The resorbable repair device is implanted into a prepared hole in the bone, and is used to reattach damaged soft tissue. The suture anchors are made of a resorbable copolymer, derived from glycolide and lactide colored with D&C violet #2. The glycolide/lactide copolymer degrades and resorbs IN VIVO by hydrolysis to lactic and glycolic acids which are then metabolized by the body. U.S.P. size 2-0 (3 metric) TICRON™ polyester sutures are nonabsorbable, sterile, surgical sutures composed of polyethylene terephthalate. The braided sutures are coated uniformly with silicone to increase surface lubricity, thereby enhancing handling characteristics, ease of passage through tissue and knot run-down properties. TICRON polyester sutures are inert and elicit only minimal local tissue reaction. They are also available dyed with D&C blue No. 6 colorant and are also available undyed (white). TICRON sutures meet all requirements established by the United States Pharmacopeia (USP) and the European Pharmacopeia (EP) for nonabsorbable surgical sutures except where indicated on the individual unit package.
    Info USS Sports Medicine
    Customer Service: (800) 423-8772
    Web site: http://www.tycohealthcare.com

    Related medicine products :

    1. POLYSORB™ Soft Tissue Reattachment System, 3mm
    2. Straight Tissue Forceps
    3. Bishop-Harmon Straight Tissue Forceps
    4. Bishop-Harmon Curved Tissue Forceps
    5. Straight Tissue Forceps - Non-Magnetic
    6. Programmable Tissue Stainer TST 40, 115V, 60Hz, 100VA
    7. Programmable Tissue Stainer TST 40, 230V, 50Hz, 100VA
    8. Tissue-Tek DRS 2000
    9. Micro Tissue Forceps
    10. Micro Tissue Forceps with round handle
    11. LICOX Brain Tissue Oxygen Monitoring System
    ...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
    ...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
    ...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
    ...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
    Medicine Products:
    (Date:7/25/2008)...erican Society for Gastrointestinal Endoscopy (ASG...in the bariatric surgery patient. The rising preva...ess in surgical interventions led to a marked incr...med in the U.S., from 13,365 in 1998 to 102,794 in...operative patient and the postoperative patient, a...
    (Date:7/25/2008)...er of jobs created in the medical field slowed in ...t kind of slowdown: they laid off fewer people in ... Seattle, WA (PRWEB) July 25, 2008 -- Though...lowed in June overall, pharmaceutical companies re...usic to the ears of sales representatives: fewer l...
    (Date:7/25/2008)...xclusivity Begins -, CORONA, Calif., July 25 /PRN... (NYSE: WPI ), a leading specialty pharmaceutical...commenced commercial,shipment of its Omeprazole De...ength from its Davie, Florida manufacturing facili... days of marketing exclusivity for being the,first...
    (Date:7/25/2008).../ -- Sagent Pharmaceuticals, Inc.,a privately-hel...d that it,has launched amiodarone HCl injection, U...reatment and prophylaxis of frequently recurring,v...le ventricular,tachycardia -- a potentially life-t...ne HCl injection will be available immediately in ...
    Breaking Medicine News(10 mins):Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3
    ... put on the national agenda by India's political l...re pressing problems. // Sam Pitroda was right in... for selecting students for institutions of higher... of increasing the number of Indian Institutes of ...
    ...alth Organization (WHO), Dr Anders Nordstrom, addr... office // , confirmed that Dr Anders Nordstrom. H...l resources and the support from the people to con...ria and polio. He reiterated that he would contin...
    ...IDS. It is waiting for the FDA to give it an appro... company already sells the kit to hospitals and pu...ug Michels, thinks that this product would become ...lmost 25 years since the first AIDS diagnosis was ...
    ...new strain of E. coli O157was responsible for the ... in Europe and Australia, but is apparently very r...ntly in the laboratory from other types of E.coli ...d in finding out more about it,' said HPS consulta...
    Other Medicine News:Health News:Quota System: Diverting Attention From The Real Problem 2Health News:Quota System: Diverting Attention From The Real Problem 3Health News:Quota System: Diverting Attention From The Real Problem 4
    (Date:7/24/2008)...wswire-USNewswire/ -- Headlines claiming "soy,prod...y. The small scale,preliminary study that Dr. Jor...n, is based on recollected intake of soyfoods and ...tudy is confounded by many,issues, thus I feel the...tion," warned Dr. Tammy Hedlund, a researcher in p...
    (Date:7/24/2008)...wire-FirstCall/ -- MacroChem Corporation (OTC,Bull...se 2 clinical trial,involving 37 patients who comp...icacy and safety study of EcoNail, a topical antif...nail fungus). The composite,primary efficacy endpo...gative mycology (negative fungal culture and negat...
    (Date:7/23/2008)...lication in July print edition of Clinical ...APOLIS, July 23 /- A Roche Diagnostic...rminal pro-B-type natriuretic peptide,(NT-proBNP) ...,stratification in predicting the risk of cardiova...with non-steroidal anti-inflammatory drugs of,the ...
    (Date:7/23/2008)...re/ -- FluoroPharma Inc., a company developing,bre...n Emission Tomography,(PET) market, announced posi...-18 labeled tracer for myocardial perfusion imagin...roduct to complete Phase I clinical,development., ...the blood flow in the,heart (myocardial perfusion)...
    Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy 3713 1Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy 3713 2Easter Seals Awards State and Municipal Public Officials With 2007 Outstanding Advocate Awards 3711 1Easter Seals Awards State and Municipal Public Officials With 2007 Outstanding Advocate Awards 3711 2James B Hawkins Appointed to IRIDEX Board of Directors 3709 1James B Hawkins Appointed to IRIDEX Board of Directors 3709 2James B Hawkins Appointed to IRIDEX Board of Directors 3709 3The First Mega Shelter Arrangement in Oregon Created for Major Disaster Response and Recovery 3707 1The First Mega Shelter Arrangement in Oregon Created for Major Disaster Response and Recovery 3707 2The First Mega Shelter Arrangement in Oregon Created for Major Disaster Response and Recovery 3707 3
    ...Accentia,Biopharmaceuticals, Inc. (NASDAQ: ABPI), ...he American Academy of Allergy, Asthma, and,Immuno... The,posters discussed findings from a survey of 2...U.S., U.K., France, and Germany on the,burden of c... of,the fungal etiology of CS, and the differences...
    ...- Advanced Viral,Research Corp. (OTC Bulletin Boar...oday that new information on AVR118 has been,accep... American,Society of Clinical Oncology (ASCO) Abst...uted to the nearly 25,000 oncology,practioners who...on,June 1-5., Based on recent work conducted by AD...
    Other Medicine Technology:Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 2Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 3Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 5American Society of Clinical Oncology (ASCO) Accepts New Data on,AVR118 for Publication in 2007 Abstract Book 2American Society of Clinical Oncology (ASCO) Accepts New Data on,AVR118 for Publication in 2007 Abstract Book 3